ERBB2 and breast cancer: Interestingly, Gregory Weitsman and colleagues introduced a FLIM-FRET technique for quantifying HER2-HER3 dimers in BC tissues, demonstrating that the dimerization of HER2 and HER3 is associated with metastatic relapse in BC patients [37].